Analyst Ratings for Cardiome Pharma (CRME)

CRME Rating Summary

CRME Price Target Summary

* Over Last 12-Mos
  |   Expand Research on CRME
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $9.25 (+14.1%) * Over Last 12-Mos
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
6/17/2014 Mackie Research New Coverage Spec. Buy
(N/A)
9.50
(N/A)
7.01 8.11 15.69% Details
1/7/2014 R.F. Lafferty New Coverage Buy
(N/A)
9.00
(N/A)
6.10 8.11 32.95% Details